Intercytex Ltd is a UK-based regenerative medicine company established in 2000. Specializing in biotechnology and wellness beauty industries, it is dedicated to developing its lead product, ICX-RHY, to address various skin-related conditions such as Epidermolysis Bullosa (EB) and scar contractures. The company secured a £2.75M Venture Round investment on September 9, 2008. Despite the lack of specific details about the investors, this investment marked a significant milestone for Intercytex Ltd's growth and product development.
Intercytex Ltd
Founded 2000
6 employees
Venture round
Total: $26.15M
Biotechnology, Wellness Beauty
General Information
Company Name
Intercytex Ltd
Founded Year
2000
Employees
6
Industries
Biotechnology, Wellness Beauty
Funding Stage
Venture round
BounceWatch is an independent company data service, not affiliated with Intercytex Ltd. To contact Intercytex Ltd, visit intercytex.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Intercytex Ltd compare?
A PDF of Intercytex Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Intercytex Ltd soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Intercytex Ltd
Business keywords: Regenerative Medicine, Cell Therapy, Skin Repair, Cell-Based Therapies, Clinical Trials, Stem Cell Research, Wound Healing, Skin Regeneration, Bioengineering, UK Biotech, Medical Innovation, Epidermolysis Bullosa Treatment, Scar Contractures Treatment
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | £2.75M | - |
|
09 Sep 2008 |
| Series D | £12.00M | 5 |
|
01 Aug 2005 |
| Venture Round | £1.00M | 1 |
|
01 Aug 2003 |
| Venture Round | £9.00M | 1 |
|
21 Mar 2003 |
| Venture Round | $1.40M | 1 |
Avlar BioVentures
|
27 Feb 2000 |
Intercytex Ltd Alternatives & Competitors
View All Alternatives
Intercytex Ltd vs
CUTISS AG
Switzerland
FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company
Series C
66 employees
Biotechnology, Health Care
Intercytex Ltd vs
Intercytex Ltd vs
Heartseed Inc.
Japan
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiomyocytes fo...
IPO
21 employees
Biotechnology, Care Economy
FAQ About Intercytex Ltd
Welcome to Intercytex Ltd. We are a UK Regenerative Medicine product and services company, focused on developing our lead product ICX-RHY to treat a variety of skin related problems including Epidermolysis Bullosa (EB) and scar contractures.
Intercytex Ltd was founded in 2000.
Intercytex Ltd operates in Biotechnology and Wellness Beauty. Its work centres on Regenerative Medicine, Cell Therapy, Skin Repair and Cell-Based Therapies.
Intercytex Ltd has approximately 6 employees.
Intercytex Ltd has completed 5 funding rounds, raising a total of $26.15M. The latest funding stage is Venture round.
Top alternatives and competitors to Intercytex Ltd include CUTISS AG, Colzyx, Heartseed Inc., Cellestetix, ExoCoBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Intercytex Ltd and CUTISS AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Intercytex Ltd, https://bouncewatch.com/company/intercytex-ltd, updated 27 December 2024. When citing, please name BounceWatch and link this page.
